Anondita Medicare Ltd (ANONDITA) — shareholding pattern, promoter holding, financials and share price

About Anondita Medicare Ltd (ANONDITA)

Anondita Medicare Ltd operates in the Personal Care industry, within the Fast Moving Consumer Goods sector. It trades on the NSE as ANONDITA and on the BSE under scrip code 94286. Its ISIN is INE0VTV01012.

Founded in March 2024, Anondita Medicare Limited manufactures flavored male condoms, with its flagship product branded as “COBRA.” [1]

Listed peers in Personal Care: Radix Industries (India) Ltd, Macobs Technologies Ltd, Sat Kartar Life Ltd, Thrive Future Habitats Limited, Ravelcare Ltd.

Valuation & Returns

10 Jul 2026

At ₹1,160.6 a share on 10 Jul 2026, Anondita Medicare Ltd (ANONDITA) was valued at a price-to-earnings ratio of 62.77x against an industry P/E of 46.1x and a price-to-book of 16.24x on a book value of ₹71.45 per share. Solomo computes return on equity of 25.88% and return on capital employed of 30.97% from filed results.

P/E
62.77x
Industry P/E
46.1x
P/B
16.24x
EPS (TTM)
₹18.49
Book value / share
₹71.45
ROE
25.88%
ROCE
30.97%
ROA
18.56%
Debt / equity
0.26x
Dividend yield
0%
EBITDA margin
37.48%
52-week range
₹261.75 – ₹1,316

Ratios are computed from filed results and the last recorded price. Not investment advice.

Financial Performance

Mar 2026

In the year ended Mar 2026, Anondita Medicare Ltd (ANONDITA) reported revenue of ₹137 crore, net profit of ₹34 crore and earnings per share of ₹18.49. That compares with revenue of ₹77 crore and net profit of ₹16 crore in Mar 2025. Figures are consolidated, as filed with the exchanges.

In the quarter ended Mar 2026, revenue was ₹83 crore and net profit ₹21 crore (consolidated).

Consolidated annual results for Anondita Medicare Ltd (ANONDITA), Mar 2025 to Mar 2026. Revenue and net profit in ₹ crore; EPS in ₹ per share.
MetricMar 2025Mar 2026
Revenue (₹ cr)77137
Net profit (₹ cr)1634
EPS (₹)11.8818.49

Ownership Summary

Mar 2026

As of Mar 2026, promoters hold 62.4% of Anondita Medicare Ltd (ANONDITA). Market capitalisation was ₹2,099 crore on 10 Jul 2026. Shareholding is filed quarterly with BSE and NSE; Solomo carries every filing back to Sep 2025.

Largest disclosed public shareholders in Mar 2026: MOHEET VINODKUMAR AGARWAL 3.05%, SAGEONE - FLAGSHIP GROWTH OE FUND 2.92%, VIKASA INDIA EIF I FUND - INCUBE GLOBAL OPPORTUNITIES 2.12%, RITU BAPNA 1.91%, SAGEONE - FLAGSHIP GROWTH 2 1.75%, MANSI SHARE & STOCK BROKING PRIVATE LIMITED 1.63%. Only stakes above the 1% disclosure threshold are named in filings.

QuarterPromoterPledgedFIIDIIPublic
Mar 202662.4%----
Sep 202561.79%----
Every quarter since Sep 2025 Filing data, not investment advice.